Literature DB >> 2706208

Efficacy of Nd-YAG laser iridotomies in acute angle closure glaucoma.

R H Gray1, J H Nairne, W H Ayliffe.   

Abstract

Between September 1984 and April 1987 a total of 150 patients underwent Nd-YAG laser iridotomy procedures at the Bristol Eye Hospital. Forty of these patients (27%) were treated for acute angle closure glaucoma (AACG), and three of them (7%) suffered recurrent AACG. Sixteen patients who had been treated for AACG have been challenged by a pharmacological provocative test introduced by Mapstone, with a total of 23 eyes being tested. A negative result was obtained in all cases. Provocative testing is recommended to help identify those at risk of recurrent AACG.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2706208      PMCID： PMC1041687          DOI： 10.1136/bjo.73.3.182

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  11 in total

1.  Provocative tests in closed-angle glaucoma.

Authors:  R Mapstone
Journal:  Br J Ophthalmol       Date:  1976-02       Impact factor: 4.638

2.  Neodymium-YAG laser iridectomies in glaucoma associated with closed or occludable angles.

Authors:  L W Schwartz; M R Moster; G L Spaeth; R P Wilson; E Poryzees
Journal:  Am J Ophthalmol       Date:  1986-07-15       Impact factor: 5.258

3.  Peripheral iridectomy in closed angle glaucoma-- late complications.

Authors:  N Floman; D Berson; L Landau
Journal:  Br J Ophthalmol       Date:  1977-02       Impact factor: 4.638

4.  A comparison of neodymium: YAG and argon laser iridotomies.

Authors:  A L Robin; I P Pollack
Journal:  Ophthalmology       Date:  1984-09       Impact factor: 12.079

5.  Q-switched neodymium:YAG laser iridotomy.

Authors:  R M Klapper
Journal:  Ophthalmology       Date:  1984-09       Impact factor: 12.079

6.  Argon laser peripheral iridotomies in the treatment of primary angle closure glaucoma. Long-term follow-up.

Authors:  A L Robin; I P Pollack
Journal:  Arch Ophthalmol       Date:  1982-06

7.  The long-term effects of iridectomy for primary acute angle-closure glaucoma.

Authors:  T Krupin; K B Mitchell; M F Johnson; B Becker
Journal:  Am J Ophthalmol       Date:  1978-10       Impact factor: 5.258

8.  The fellow eye.

Authors:  R Mapstone
Journal:  Br J Ophthalmol       Date:  1981-06       Impact factor: 4.638

9.  Laser iridectomy. A controlled study comparing argon and neodymium: YAG.

Authors:  M R Moster; L W Schwartz; G L Spaeth; R P Wilson; J A McAllister; E M Poryzees
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

10.  Long-term follow-up of laser iridotomy.

Authors:  H A Quigley
Journal:  Ophthalmology       Date:  1981-03       Impact factor: 12.079
View more
  7 in total

1.  A photometric study of the effect of pupil dilatation on Nd:YAG laser iridotomy area.

Authors:  B W Fleck; E Fairley; E Wright
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

2.  Surgical results and complications of goniosynechialysis.

Authors:  H Tanihara; K Nishiwaki; M Nagata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Does the pilocarpine phenylephrine provocative test help in the management of acute and subacute angle closure glaucoma?

Authors:  P K Wishart
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

4.  Acute closed-angle glaucoma and Nd-YAG laser iridotomy.

Authors:  D C Saunders
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

5.  How large must an iridotomy be?

Authors:  B W Fleck
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

6.  A randomised prospective comparison of operative peripheral iridectomy and Nd:YAG laser iridotomy treatment of acute angle closure glaucoma: 3 year visual acuity and intraocular pressure control outcome.

Authors:  B W Fleck; E Wright; E A Fairley
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

7.  Acute angle closure glaucoma: relative failure of YAG iridotomy in affected eyes and factors influencing outcome.

Authors:  S A Buckley; B Reeves; M Burdon; C Moorman; S Wheatcroft; C Edelsten; L Benjamin
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.